GUMDROP : WRNMMC - A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

Created by Nancy Dawson, last modified on Sep 13, 2013
Description:The purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from metastatic, castrate-resistant prostate cancer.
Link:http://clinicaltrials.gov/ct2/show/NCT01322490
Site:Walter Reed National Military Medical Center
Principle Investigator:David McLeod, MD